Paper

Chromium picolinate for reducing body weight: Meta-analysis of randomized trials

  • International Journal of Obesity volume 27, pages 522529 (2003)
  • doi:10.1038/sj.ijo.0802262
  • Download Citation
Received:
Revised:
Accepted:
Published:

Subjects

Abstract

The aim of this meta-analysis was to assess the evidence of chromium picolinate for reducing body weight. Literature searches were conducted on Medline, Embase, The Cochrane Library, Amed and Ciscom. Nine experts and four manufacturers of commercial preparations containing chromium picolinate were asked to contribute published and unpublished studies. There were no restrictions regarding the language of publication. The screening of studies, selection, data extraction, validation and the assessment of methodological quality were performed independently by two reviewers. To be included, studies were required to state that they were randomized, double-blind and placebo-controlled, and report on body weight. Ten trials met all inclusion criteria and provided data, which were suitable for statistical pooling. For body weight a significant differential effect was found in favour of chromium picolinate (weighted mean difference: −1.1 kg; 95% confidence interval (CI): −1.8 to −0.4 kg, n=489). Sensitivity analysis suggests that this effect is largely dependent on the results of a single trial (weighted mean difference: −0.9 kg; 95% CI: −2.0 to 0.2 kg, n=335). Three of the reviewed trials reported on adverse events, indicating their absence in the treatment groups. In conclusion, our meta-analysis suggests a relatively small effect of chromium picolinate compared with placebo for reducing body weight. The clinical relevance of the effect is debatable and the lack of robustness means that the result has to be interpreted with caution.

  • Subscribe to International Journal of Obesity for full access:

    $652

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    World Health Organization. Obesity: preventing and managing the global epidemic. World Health Organization: Geneva; 1998.

  2. 2.

    National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity and health risk. Arch Int Med 2000; 160: 898–904.

  3. 3.

    , , , , , , , . Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Int Med 2001; 161: 1581–1586.

  4. 4.

    , , , . The effect of diet on risk of cancer. Lancet 2002; 360: 861–868.

  5. 5.

    , , , , , , , . Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305–313.

  6. 6.

    , , , . Prevalence and trends in obesity among US adults 1999–2000. JAMA 2002; 288: 1723–1727.

  7. 7.

    Department of Health: Obesity. Reversing the increasing problem of obesity in England. DoH: UK: 1995.

  8. 8.

    . As obesity rates rise, experts struggle to explain why. Science 1998; 280: 1367–1368.

  9. 9.

    , . Obesity in Britain: gluttony or sloth? BMJ 1995; 311: 437–439.

  10. 10.

    , . Divergent trends in obesity and fat intake patterns: the American paradox. Am J Med 1997; 102: 259–264.

  11. 11.

    . Effects of chromium on body composition and weight loss. Nutr Rev 1998; 56: 266–270.

  12. 12.

    , . Chromium in human nutrition. Ann Rev Nutr 1988; 8: 543–563.

  13. 13.

    . Chromium in human nutrition: a review. J Nutr 1993; 123: 626–633.

  14. 14.

    . Essentiality of chromium in humans. Sci Total Environ 1989; 86: 75–81.

  15. 15.

    , (eds). Textbook of natural medicine. Churchill Livingstone: London; 1999. pp 1434–1436.

  16. 16.

    , (eds). Encyclopedia of natural medicine (2nd rev. edn). Prima Publishing: Rocklin; 1998. pp 690–691.

  17. 17.

    (Ed). Encyclopedia of nutritional supplements. Prima Publishing: Rocklin, 1996. pp 317–319.

  18. 18.

    , , , , , , , . Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews. BMJ 1998; 317: 1562–1563.

  19. 19.

    , , , , , et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1–12.

  20. 20.

    , , , . Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992; 45: 769–773. Cited in: Clarke M, Oxman AD (eds). Cochrane Reviewers Handbook 4.1.5. In: The Cochrane Library, Issue 2. Update Software. Oxford; 2002.

  21. 21.

    , , , . Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr 2001; 20: 293–306.

  22. 22.

    , , , , . A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr Ther Res 1998; 59: 379–388.

  23. 23.

    , , , . Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study. Curr Ther Res 1996; 57: 747–756.

  24. 24.

    , , , . Chromium picolinate effects on body composition and muscular performance in wrestlers. Med Sci Sports Exer 1998; 30: 1730–1737.

  25. 25.

    , , . The effect of chromium picolinate on muscular strength and body composition in women athletes. J Strength Cond Res 2001; 15: 161–166.

  26. 26.

    , , , , , . Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men. J Appl Physiol 1999; 86: 29–39.

  27. 27.

    , , , , . Effect of resistance training with or without chromium picolinate supplementation on glucose metabolism in older men and women. Metabolism 1999; 48: 546–553.

  28. 28.

    , , , . Effects of chromium picolinate on beginning weight training students. Int J Sports Nutr 1992; 2: 343–350.

  29. 29.

    , , , , , . Effects of chromium and resistive training on muscle strength and body composition. Med Sci Sports Exer 1996; 28: 139–144.

  30. 30.

    , , , . Chromium and exercise training: effect on obese women. Med Sci Sports Exer 1997; 29: 992–998.

  31. 31.

    , . Effect of chromium picolinate on body composition. J Sports Med Phys Fitness 1995; 35: 273–280.

  32. 32.

    , , , . Chromium supplementation and resistance training: effects on body compositon, strength and trace element status of men. Am J Clin Nutr 1996; 63: 954–965.

  33. 33.

    , , , , , , . The short-term therapeutic efficacy of treating obesity with a plan of improved nutrition and moderate caloric restriction. Curr Ther Res 1992; 51: 261–275.

  34. 34.

    , , . Effects of carbohydrate and chromium ingestion during intermittent high-intensity exercise to fatigue. Int J Sport Nutr Exer Metab 2000; 10: 476–485.

  35. 35.

    , , , , , , , , . Clinical evidence for effectiveness of phencal in maintaining weight loss in an open label, controlled 2-year study. Curr Ther Res 1997; 58: 745–763.

  36. 36.

    , . Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Res 1995; 28: 179–184.

  37. 37.

    , , , , , . Chromium supplementation of human subjects: effects on glucose, insulin and lipid variables. Metabolism 1983; 32: 894–899.

  38. 38.

    , , . The effectiveness of long-term supplementation of carbohydrate, chromium, fibre, and caffeine on weight maintenance. Int J Obesity 1997; 21: 1143–1151.

  39. 39.

    . Effect of chromium supplementation on glucose tolerance and lipid profile. Saudi Med J 2000; 21: 45–50.

  40. 40.

    , , , , , . Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 2001; 20: 212–218.

  41. 41.

    , , . Effects of chromium picolinate supplementation on insulin sensitivity serum lipids and body composition in healthy nonobese older men and women. J Gastroenterol 2000; 55A: M260–M263.

  42. 42.

    , , , . Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. J Trace Elements Exp Med 1995; 8: 183–190.

  43. 43.

    , , . The effects of chromium picolinate supplementation on body composition in different age groups. Age 1991; 14: 138.

  44. 44.

    , , , , . Chromium picolinate supplementation and resistive training by older men: effects on iron-status and hematologic indexes. Am J Clin Nutr 1997; 66: 944–949.

  45. 45.

    , . Beneficial effects of chromium picolinate supplementation on serum triglyceride levels in NIDDM. Diabetes Care 1994; 17: 1449–1452.

  46. 46.

    , , , , , , . Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997; 46: 1786–1791.

  47. 47.

    , , , , , , . Effects of chromium picolinate supplementation on body composition, strength and urinary chromium loss in football players. Int J Sports Nutr 1994; 4: 142–153.

  48. 48.

    , , . The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med 1990; 152: 41–45.

  49. 49.

    , , , , . Effekt von Chromhefe und Chrompicolinat auf die Körperzusammensetzung bei übergewichtigen, nichtdiabetischen Patienten während und nach einer Formula-Diät. Acta Med Aust 1997; 24: 185–187.

  50. 50.

    . The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosocial Med Res 1989; 11: 163–180.

  51. 51.

    , , . Obesity management by life-style strategies. Br Med Bull 1997; 53: 389–408.

  52. 52.

    , . Obesity. BMJ 2001; 322: 1406–1409.

  53. 53.

    , , et al. Trends in alternative medicine use in the United States 1990–1997: results of a national follow-up survey. JAMA 1998; 280: 1569–1575.

  54. 54.

    , , . Use of nonprescription weight loss products. Results from a multistate survey. JAMA 2001; 286: 930–935.

  55. 55.

    , , . The effectiveness of popular, non-prescription weight loss supplements. Med J Aust 1999; 171: 604–608.

  56. 56.

    , , , , . Alternative treatments for weight loss: a critical review. Crit Rev Food Sci Nutr 2001; 41: 1–28.

  57. 57.

    , , , . Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB 1995; 9: 1643–1648.

  58. 58.

    , , . Lack of toxicity of chromium chloride and chromium picolinate in rats. J Am Coll Nutr 1997; 16: 273–279.

  59. 59.

    , , , , , , . Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil. Eur J Epidemiol 1998; 14: 621–626.

  60. 60.

    , . Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998; 18: 860–862.

  61. 61.

    , , . Rhabdomyolysis associated with nutritional supplement use. J Clin Rheumatol 2000; 6: 328–332.

  62. 62.

    , , , , . Chromium picolinate toxicity. Ann Pharmacother 1998; 32: 428–431.

  63. 63.

    , , , . Acute generalized exanthematous pustulosis induced by chromium picolinate. J Am Acad Dermatol 1999; 41: 820–823.

  64. 64.

    . The existence of publication bias and risk factors for its occurrence. JAMA 1990; 263: 1385–1389.

  65. 65.

    , , , . Publication bias in clinical research. Lancet 1991; 337: 867–872.

  66. 66.

    , . Bias in location and selection of studies. BMJ 1998; 316: 61–66.

  67. 67.

    , . Alternative therapy bias. Nature 1997; 385: 480.

  68. 68.

    , , . Bias in alternative medicine is still rife but is diminishing. BMJ 2001; 323: 1071.

  69. 69.

    , , , . Location bias in controlled clinical trials of complementary/alternative therapies. J Clin Epidemiol 2000; 53: 485–489.

  70. 70.

    , , , , , . Language bias in randomised controlled trials published in English and German. Lancet 1997; 350: 326–329.

  71. 71.

    , . Bias against European journals in medical publication databases. Lancet 1999; 353: 1592.

Download references

Author information

Affiliations

  1. Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth, Exeter, UK

    • M H Pittler
    •  & E Ernst
  2. Department of Exercise and Health Sciences, University of Bristol, Bristol, UK

    • C Stevinson

Authors

  1. Search for M H Pittler in:

  2. Search for C Stevinson in:

  3. Search for E Ernst in:

Corresponding author

Correspondence to M H Pittler.